Literature DB >> 12362410

Inflammatory processes in amyotrophic lateral sclerosis.

P L McGeer1, E G McGeer.   

Abstract

Neuroinflammation is a characteristic of pathologically affected tissue in several neurodegenerative disorders. These changes can be observed in the brainstem and spinal cord of amyotrophic lateral sclerosis (ALS) cases and in mouse models of the disease. They include an accumulation of large numbers of activated microglia and astrocytes, as well as small numbers of T cells, mostly adhering to postcapillary venules. Accompanying biochemical alterations include the appearance of numerous molecules characteristic of free-radical attack, the occurrence of proteins associated with activation of the complement cascade, and a sharp upregulation of the enzyme cyclooxygenase 2 (COX-2). Anti-inflammatory agents may have a role to play in treating ALS. COX-2 is a particularly attractive target because of its marked increase in ALS spinal cord. Copyright 2002 Wiley Periodicals, Inc. Muscle Nerve 26: 459-470, 2002

Entities:  

Mesh:

Year:  2002        PMID: 12362410     DOI: 10.1002/mus.10191

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  167 in total

Review 1.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

2.  High-resolution diffusion tensor imaging of the brain stem at 3 T.

Authors:  Lidia M Nagae-Poetscher; Hangyi Jiang; Setsu Wakana; Xavier Golay; Peter C M van Zijl; Susumu Mori
Journal:  AJNR Am J Neuroradiol       Date:  2004-09       Impact factor: 3.825

3.  Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics.

Authors:  Henrik Ryberg; Jiyan An; Samuel Darko; Jonathan Llyle Lustgarten; Matt Jaffa; Vanathi Gopalakrishnan; David Lacomis; Merit Cudkowicz; Robert Bowser
Journal:  Muscle Nerve       Date:  2010-07       Impact factor: 3.217

4.  Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

Authors:  David R Beers; Weihua Zhao; Bing Liao; Osamu Kano; Jinghong Wang; Ailing Huang; Stanley H Appel; Jenny S Henkel
Journal:  Brain Behav Immun       Date:  2010-12-19       Impact factor: 7.217

Review 5.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 6.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

7.  Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.

Authors:  Larry Lam; Ramesh C Halder; Dennis J Montoya; Liudmilla Rubbi; Arturo Rinaldi; Bien Sagong; Sarah Weitzman; Rachel Rubattino; Ram Raj Singh; Matteo Pellegrini; Milan Fiala
Journal:  Am J Neurodegener Dis       Date:  2015-12-28

Review 8.  Microglia.

Authors:  Denise van Rossum; Uwe-Karsten Hanisch
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

9.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

10.  T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.

Authors:  Isaac M Chiu; Adam Chen; Yi Zheng; Bela Kosaras; Stefanos A Tsiftsoglou; Timothy K Vartanian; Robert H Brown; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.